MediWound MDWD Cash Flow Statement (2013-2026)

NASDAQ MDWD
$13.73 -0.11 (-0.79%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

MediWound Quarterly Cash Flow Statement

Periods 54 quarters
Latest Jun 2026

MediWound reported cash from operations of -$9.13M and free cash flow of -$8.05M for the quarter ended Jun 2026, down 58.6% year over year. This cash flow statement covers 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-3.35M-4.16M-3.59M4.35M-4.20M-7.46M-3.69M0.92M-2.20M-1.74M-9.73M-6.31M-10.28M-3.91M-0.73M13.32M-2.65M40.58M-2.95M7.39M
Share-based CompensationStock Comp.
0.40M0.39M0.34M0.25M0.71M0.64M0.62M0.71M0.31M0.30M0.51M0.76M1.05M0.82M0.84M0.86M0.74M0.66M0.64M0.76M
Cash from Discontinued OperationsCash from Discont. Ops
Non-cash ItemsNon-Cash Items
-1.30M-0.97M1.13M-1.73M-10.88M-0.25M-4.27M0.40M1.49M-6.88M2.99M-6.61M0.96M3.29M8.66M2.71M-0.72M4.01M-1.11M
Cash from OperationsCash from Ops.
-2.82M-2.23M-4.07M-5.25M0.75M0.65M-5.25M-3.25M-2.62M-4.61M-3.62M-3.76M-1.64M-4.11M-5.76M-3.24M-3.02M-6.75M-9.13M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.34M0.28M0.32M0.33M0.34M0.28M0.30M0.32M0.34M0.35M0.37M0.36M0.36M0.40M0.36M0.39M0.42M0.69M0.38M0.40M
Change in Working Capital
Change in ReceivablesChange Receivables
0.02M0.23M-0.58M-1.45M-0.42M-5.14M6.82M-0.71M0.07M-0.53M-0.12M0.88M-0.47M-1.43M1.45M-1.67M0.68M2.75M0.40M-0.48M
Change in InventoryChange Inventory
0.17M0.07M-0.71M-0.04M0.14M-0.11M-0.58M-0.58M-0.53M0.78M-0.45M0.10M0.18M0.35M-0.89M-0.26M-0.56M0.35M-0.69M0.66M
Change in Account PayablesChange Payables
-0.34M-0.82M0.28M-0.27M-0.46M0.78M-0.17M0.31M0.29M1.09M-1.37M-0.53M-0.05M2.35M-0.10M0.79M1.72M-0.06M-0.19M0.04M
Change in Accured ExpensesChange Accured Exp.
0.01M0.99M-1.24M0.78M-1.95M-0.05M1.09M-1.37M-0.05M
Investing Activities
Capital ExpendituresCapex
-0.13M-0.12M-0.16M-0.14M-0.08M-0.17M-1.50M-1.06M-1.69M-2.21M-1.26M-3.02M-1.19M-0.81M-0.96M-1.05M-1.04M-2.45M-1.82M-1.07M
Divestments
Change in Acquisitions & DivestmentsChange Acquisitions
-2.50M-6.24M-25.59M-4.49M6.51M-1.13M5.34M-13.55M4.97M-2.65M5.63M4.60M-21.62M19.00M-1.40M
Cash from Investing ActivitiesCash from Investing
-0.13M-0.12M-0.16M-2.64M-0.08M2.40M-7.44M-26.08M-5.83M5.03M-1.78M2.85M-14.29M4.83M-3.34M4.91M4.38M-23.89M17.76M-2.39M
Financing Activities
Other financing activitiesOther financing
-4.00M10.42M12.05M2.51M25.16M-0.25M-24.91M0.50M0.11M0.60M0.84M2.79M0.01M0.77M
Cash from Financing ActivitiesCash from Financing
-0.36M-0.18M10.08M-0.73M11.78M14.64M24.25M-0.41M-0.73M-0.20M-0.70M-0.10M20.71M-0.51M-0.36M0.55M30.52M-1.09M-0.42M0.40M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
10.42M-0.56M25.16M-0.25M0.50M22.44M-0.50M28.17M-0.75M
Additional items
Exchange Rate EffectFX Effect
-0.01M-0.11M-0.25M-0.30M0.04M-0.04M-0.34M-0.12M-0.08M0.38M-0.09M-0.01M0.02M0.00M0.02M0.00M0.01M0.06M-0.03M0.11M
Change in Cash
-3.31M-2.64M5.61M-8.92M7.18M18.99M17.12M-31.85M-9.89M2.59M-7.18M-0.90M2.69M2.68M-7.80M-0.30M31.68M-27.94M10.55M-11.01M
Free Cash FlowFCF
-2.69M-2.12M-3.90M-5.12M0.08M0.92M2.16M-4.19M-1.57M-0.41M-3.35M-0.61M-2.56M-0.83M-3.15M-4.71M-2.19M-0.56M-4.93M-8.05M
Net Cash FlowNCF
-3.30M-2.53M5.85M-8.62M11.70M17.78M17.46M-31.73M-9.81M2.21M-7.09M-0.88M2.67M2.68M-7.82M-0.30M31.66M-28.00M10.58M-11.12M